Molecular Diagnosis and Outcome Prediction in Diffuse Large B-Cell Lymphoma and Other Subtypes of Lymphoma

Karen Dybkær(Aalborg University Hospital), Wing C. Chan(Ontario Institute for Cancer Research), Javeed Iqbal(University of Nebraska Medical Center), Guimei Zhou(University of Nebraska Medical Center)
Clinical Lymphoma
June 1, 2004
10.3816/clm.2004.n.006
Cited by 23

Related Papers

The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k
Stromal Gene Signatures in Large-B-Cell Lymphomas
|New England Journal of Medicine|2008|1.8k
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
|Nature|2010|1.6k
Oncogenically active MYD88 mutations in human lymphoma
|Nature|2010|1.5k